News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
242,583 Results
Type
Article (19541)
Company Profile (133)
Press Release (222895)
Multimedia
Podcasts (58)
Webinars (13)
Section
Business (72894)
Career Advice (960)
Deals (12759)
Drug Delivery (42)
Drug Development (29360)
Employer Resources (73)
FDA (3972)
Job Trends (4805)
News (118898)
Policy (8656)
Tag
Academia (552)
Accelerated approval (13)
Adcomms (16)
Allergies (40)
Alliances (21595)
ALS (76)
Alzheimer's disease (638)
Antibody-drug conjugate (ADC) (191)
Approvals (4029)
Artificial intelligence (208)
Autoimmune disease (73)
Automation (14)
Bankruptcy (89)
Best Places to Work (3228)
BIOSECURE Act (20)
Biosimilars (91)
Biotechnology (118)
Bladder cancer (73)
Brain cancer (27)
Breast cancer (259)
Cancer (2105)
Cardiovascular disease (135)
Career advice (790)
Career pathing (23)
CAR-T (178)
CDC (5)
Cell therapy (464)
Cervical cancer (14)
Clinical research (25314)
Collaboration (900)
Company closure (3)
Compensation (275)
Complete response letters (32)
COVID-19 (908)
CRISPR (42)
C-suite (462)
Cystic fibrosis (62)
Data (2545)
Denatured (10)
Depression (54)
Diabetes (139)
Diagnostics (1613)
Digital health (8)
Diversity (3)
Diversity, equity & inclusion (21)
Drug discovery (142)
Drug pricing (42)
Drug shortages (2)
Duchenne muscular dystrophy (111)
Earnings (23025)
Editorial (25)
Employer branding (8)
Employer resources (73)
Events (38443)
Executive appointments (556)
FDA (5004)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (3)
Frontotemporal dementia (14)
Funding (752)
Gene editing (105)
Generative AI (22)
Gene therapy (362)
GLP-1 (399)
Government (895)
Grass and pollen (2)
Guidances (116)
Healthcare (3292)
HIV (10)
Huntington's disease (33)
IgA nephropathy (51)
Immunology and inflammation (166)
Immuno-oncology (30)
Indications (28)
Infectious disease (1016)
Inflammatory bowel disease (114)
Inflation Reduction Act (4)
Influenza (51)
Intellectual property (106)
Interviews (142)
IPO (5346)
IRA (14)
Job creations (1655)
Job search strategy (712)
Kidney cancer (7)
Labor market (56)
Layoffs (245)
Leadership (25)
Legal (2023)
Liver cancer (33)
Longevity (6)
Lung cancer (275)
Lymphoma (185)
Machine learning (21)
Management (24)
Manufacturing (390)
MASH (58)
Medical device (1768)
Medtech (1774)
Mergers & acquisitions (7914)
Metabolic disorders (458)
Multiple sclerosis (64)
NASH (8)
Neurodegenerative disease (164)
Neuropsychiatric disorders (38)
Neuroscience (1186)
NextGen: Class of 2025 (1584)
Non-profit (501)
Now hiring (37)
Obesity (236)
Opinion (195)
Ovarian cancer (88)
Pain (61)
Pancreatic cancer (91)
Parkinson's disease (132)
Partnered (17)
Patents (193)
Patient recruitment (178)
Peanut (17)
People (25825)
Pharmaceutical (17)
Pharmacy benefit managers (3)
Phase I (9086)
Phase II (11678)
Phase III (7475)
Pipeline (1759)
Policy (122)
Postmarket research (516)
Preclinical (3669)
Press Release (62)
Prostate cancer (76)
Psychedelics (27)
Radiopharmaceuticals (106)
Rare diseases (395)
Real estate (2835)
Recruiting (40)
Regulatory (7242)
Reports (23)
Research institute (594)
Resumes & cover letters (154)
Rett syndrome (10)
RNA editing (13)
RSV (25)
Schizophrenia (46)
Series A (158)
Series B (106)
Service/supplier (7)
Sickle cell disease (43)
Special edition (15)
Spinal muscular atrophy (56)
Sponsored (15)
Startups (2031)
State (1)
Stomach cancer (7)
Supply chain (38)
Tariffs (36)
The Weekly (48)
Vaccines (355)
Venture capital (71)
Weight loss (148)
Women's health (20)
Worklife (8)
Date
Today (44)
Last 7 days (228)
Last 30 days (1049)
Last 365 days (13368)
2025 (13317)
2024 (14558)
2023 (15625)
2022 (20796)
2021 (21192)
2020 (17477)
2019 (12314)
2018 (9651)
2017 (11544)
2016 (10441)
2015 (12294)
2014 (11984)
2013 (11225)
2012 (8141)
2011 (8531)
2010 (7797)
Location
Africa (385)
Alabama (51)
Alaska (3)
Arizona (74)
Arkansas (2)
Asia (29621)
Australia (4457)
California (4343)
Canada (1325)
China (596)
Colorado (83)
Connecticut (173)
Delaware (99)
Europe (39941)
Florida (505)
Georgia (73)
Hawaii (2)
Idaho (14)
Illinois (216)
India (42)
Indiana (210)
Iowa (5)
Japan (266)
Kansas (28)
Kentucky (6)
Louisiana (7)
Maine (4)
Maryland (594)
Massachusetts (3400)
Michigan (112)
Minnesota (211)
Mississippi (1)
Missouri (29)
Montana (9)
Nebraska (6)
Nevada (31)
New Hampshire (8)
New Jersey (1148)
New Mexico (11)
New York (1052)
North Carolina (629)
North Dakota (6)
Northern California (2053)
Ohio (88)
Oklahoma (10)
Oregon (10)
Pennsylvania (802)
Puerto Rico (6)
Rhode Island (16)
South America (481)
South Carolina (7)
Southern California (1729)
Tennessee (28)
Texas (571)
United States (14691)
Utah (74)
Virginia (75)
Washington D.C. (24)
Washington State (530)
West Virginia (1)
Wisconsin (31)
242,583 Results for "sinovac biotech ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
SINOVAC Announces Receipt of Nasdaq Notice of Delisting and Intention to Appeal
November 19, 2025
·
4 min read
Press Releases
SINOVAC Announces Appointment of Independent Auditor
October 27, 2025
·
4 min read
Press Releases
Independent Sinovac Shareholders Express Strong Support for Immediate Dividend Payment
November 11, 2025
·
2 min read
Insights
Uptick in Dealmaking, Chinese Partnerships Drive Biotech’s Comeback
Biotech’s slump may finally be over in 2026. In interviews with
BioSpace
, Zymeworks’ CEO Ken Galbraith and Zai Lab’s President and COO Josh Smiley explain what’s fueling the comeback.
December 17, 2025
·
3 min read
·
Jennifer Smith-Parker
Deals
With Biotech Back, Analysts Make Their Picks for 2026
The second half finished strong after two tumultuous years. What will 2026 bring for the biotech sector?
December 22, 2025
·
2 min read
·
Annalee Armstrong
IPO
Radiopharma-Focused Aktis Squeezes in IPO to End Biotech Drought
The biotech, which has a deal with Eli Lilly worth as much as $1.1 billion, is developing two targeted radiopharmaceuticals from its miniprotein radioconjugate platform.
December 22, 2025
·
1 min read
·
Annalee Armstrong
Deals
Inside the 2026 Biotech Landscape: Innovation, Investment and Global Momentum
In this episode of Denatured, Jennifer Smith-Parker speaks to Kenneth Galbraith,
CEO of Zymeworks and Josh Smiley, president and COO of Zai Lab, about how renewed confidence is driving biotech entering 2026.
December 18, 2025
·
1 min read
·
BioSpace Insights
Press Releases
SINOVAC Announces New Board Member
June 18, 2025
·
3 min read
Sponsored
Taipei City Government Partners With Six Biotech Companies to Showcase at BIO International Convention 2025
The 2025 BIO International Convention (BIO2025), the world’s largest annual biotech event, will take place from June 16 to 19 (U.S. time) at the Boston Convention & Exhibition Center. This year, Taipei City Government is partnering with six Taipei-based biotech companies, including PanCAD.ai Co., Ltd., Instant NanoBiosensors Co., Ltd., Bened Biomedical Co., Ltd., Cancer Free Biotech Ltd., Xantho Biotechnology Co., Ltd., and Energenesis Biomedical Co., Ltd., to showcase their innovations at the Taiwan Pavilion (Booth #1645) in the Taipei Exhibition Area.
June 16, 2025
·
5 min read
Special edition
Deep Dive: Chinese Biotech Innovation Can’t Be Stopped
In this deep dive,
BioSpace
investigates China’s rise as a biotech powerhouse.
October 27, 2025
·
3 min read
·
Annalee Armstrong
1 of 24,259
Next
